Market Pathways | MedTech Regulatory & Policy (@Market_Pathways)

Market Pathways | MedTech Regulatory & Policy@Market_Pathways4y
⚕ MedTech regulatory, reimbursement and #policy made easy. We are global medical device market-access experts researching, writing and sharing the knowledge you need to keep you informed and ahead of your competition in the #medtech industry.
Download
Share
Copied
1441.5K
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2h
#ICYMI: One overlooked difference between FDA QMSR and EU MDR could complicate your risk management strategy. The #FDA and EU MDR have different expectations for medical device risk management. See how they compare:
Download
Share
Copied
0006
Market Pathways | MedTech Regulatory & Policy@Market_Pathways1d
The next chapter of #medtech is already taking shape. Explore what a new administration could mean for the industry with a FREE Market Pathways feature article:
Download
Share
Copied
0002
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2d
The right #marketaccess strategy can make all the difference in bringing medical technologies to market. We have the tools to make it easier than ever before. Get them all here:
Download
Share
Copied
0009
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3d
3 areas shaping #medtech: regulation, reimbursement, and market access. Stay informed with expert insights from the Market Pathways newsletter:
Download
Share
Copied
00011
Market Pathways | MedTech Regulatory & Policy@Market_Pathways6d
3 reasons to listen to the Market Pathways Podcast: • Stay ahead of #medtech policy • Hear from industry experts • Gain real-world insights Listen now:
Download
Share
Copied
0006
Market Pathways | MedTech Regulatory & Policy@Market_Pathways7d
1 new EU decision marks a milestone in AI regulation. Implementing Decision (EU) 2026/2274 introduces the first harmonised #AI Act standard focused on quality management systems. Get more access to docs like this from Pathways' Document Depot:
Download
Share
Copied
10018
Market Pathways | MedTech Regulatory & Policy@Market_Pathways1w
With over 4,000 documents available, staying informed about global #medtech regulations has never been more convenient. Explore global medtech regulations and policy updates with Pathways' improved Document Depot:
Share
Copied
00012
Market Pathways | MedTech Regulatory & Policy@Market_Pathways1w
5 free #medtech cheat sheets covering regulatory updates, reimbursement challenges, MDUFA VI, and more. Get key takeaways from our top 2025 articles:
Download
Share
Copied
00022
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
Market Pathways | MedTech Regulatory & Policy
RT @JAMAInternalMed: The 2025 #NIH Public Access Policy may still leave NIH-funded investigators facing new article processing charges for immediate public access, with an estimated upper-bound annual cost of more than $100 million.
Share
Copied
0301
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
EU MDR reform is in the spotlight. 3 reasons to listen: • Understand potential changes • Hear expert insights • Stay ahead of #regulatory developments Listen here:
Download
Share
Copied
00013
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
Market Pathways | MedTech Regulatory & Policy
RT @MedTechStrat: .@MedTechStrat, @Market_Pathways, and the #medtech community are already making plans for Boston. Come meet some members of our team at Booth #1136 at #MedTechCon:
Share
Copied
0201
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
1 new #FDA final order for infant monitoring #medicaldevices. The agency has codified Class II requirements for OTC pulse rate and oxygen saturation monitors. Get access to more docs like this here:
Download
Share
Copied
00124
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
FDA QMSR and EU MDR take different approaches to residual risk. Learn how manufacturers can align risk management across both markets. Read more: #medtech Source: FDA QMSR; EU MDR 2017/745
Download
Share
Copied
0005
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
What is the biggest #regulatory challenge facing #medtech companies today?
Share
Copied
10117
Market Pathways | MedTech Regulatory & Policy@Market_Pathways2w
Posts @Market_Pathways
From evolving FDA requirements to navigating global regulatory frameworks, medtech companies face an increasingly complex regulatory landscape. Explore more regulatory insights from Market Pathways:
Share
Copied
0005
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3w
Your free Market Pathways feature article is ready. 📖 Explore what a new administration could mean for the #medtech industry:
Download
Share
Copied
00111
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3w
Market Pathways | MedTech Regulatory & Policy
RT @RAPSorg: The European Medicines Agency's Committee for Medicinal Products for Human Use is planning to update a 2018 guideline on good pharmacogenomic practices.
Share
Copied
0102
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3w
#ICYMI: There’s plenty happening across the #medtech policy landscape. Catch up on RAPID, EU Joint Clinical Assessments, MDUFA VI, NTAP updates and more in the latest Market Pathways digital edition:
Download
Share
Copied
00014
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3w
Stop digging through agency websites for the #medtech docd you need. Pathways' Document Depot lets you search and filter thousands of #regulatory and market access documents from agencies around the world. Learn how to navigate the new Doc Depot:
Share
Copied
00010
Market Pathways | MedTech Regulatory & Policy@Market_Pathways3w
Market Pathways | MedTech Regulatory & Policy
RT @RAPSorg: Finalizing guidance on artificial intelligence-enabled devices throughout their product lifecycle and on pre-determined change control plans tops the to-do list for the FDA Center for Devices and Radiological Health for fiscal year 2027..
Share
Copied
0201
Show more posts